SOL Capital Management CO Cuts Holdings in CVS Health Corporation $CVS

SOL Capital Management CO cut its holdings in CVS Health Corporation (NYSE:CVS) by 14.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 63,745 shares of the pharmacy operator’s stock after selling 10,750 shares during the quarter. SOL Capital Management CO’s holdings in CVS Health were worth $4,806,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in CVS Health by 1.7% during the 2nd quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock valued at $8,305,132,000 after acquiring an additional 2,063,737 shares in the last quarter. State Street Corp grew its position in shares of CVS Health by 1.4% in the second quarter. State Street Corp now owns 58,788,585 shares of the pharmacy operator’s stock valued at $4,055,237,000 after purchasing an additional 800,414 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of CVS Health by 2.4% in the second quarter. Geode Capital Management LLC now owns 28,635,233 shares of the pharmacy operator’s stock valued at $1,966,083,000 after purchasing an additional 675,824 shares during the last quarter. Invesco Ltd. boosted its stake in CVS Health by 15.3% during the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock worth $1,623,270,000 after buying an additional 3,118,626 shares during the last quarter. Finally, Norges Bank purchased a new stake in CVS Health in the 2nd quarter valued at $1,358,698,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on CVS. Mizuho raised their price objective on shares of CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 10th. Wall Street Zen cut CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of CVS Health in a research report on Thursday, December 4th. The Goldman Sachs Group boosted their price target on shares of CVS Health from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. Finally, Robert W. Baird upped their target price on shares of CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a report on Wednesday, December 10th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $94.86.

CVS Health Price Performance

CVS Health stock opened at $78.51 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. CVS Health Corporation has a one year low of $51.79 and a one year high of $85.15. The company has a market cap of $99.66 billion, a P/E ratio of 206.61, a price-to-earnings-growth ratio of 0.75 and a beta of 0.48. The business has a fifty day moving average of $78.84 and a two-hundred day moving average of $74.26.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating the consensus estimate of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter last year, the business earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date of this dividend is Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is 700.00%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.